[1]文正燕,孙传俊,杨献光.混合谱系激酶结构域样蛋白、caspase-8及受体相互作用蛋白激酶3 mRNA在不同阶段乙型肝炎病毒感染患者中的表达及诊断价值[J].新乡医学院学报,2023,40(7):628-633.[doi:10.7683/xxyxyxb.2023.07.005]
　WEN Zhengyan,SUN Chuanjun,YANG Xianguang.Expression and diagnostic value of mixed lineage kinase domainlike protein,caspase8 and receptor interacting protein kinase 3 mRNA in patients at different stages of hepatitis B virus infection[J].Journal of Xinxiang Medical University,2023,40(7):628-633.[doi:10.7683/xxyxyxb.2023.07.005]
点击复制

混合谱系激酶结构域样蛋白、caspase-8及受体相互作用蛋白激酶3 mRNA在不同阶段乙型肝炎病毒感染患者中的表达及诊断价值
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年7
页码:
628-633
栏目:
临床研究
出版日期:
2023-07-05

文章信息/Info

Title:
Expression and diagnostic value of mixed lineage kinase domainlike protein,caspase8 and receptor interacting protein kinase 3 mRNA in patients at different stages of hepatitis B virus infection
作者:
文正燕1; 孙传俊2; 杨献光3
（1.新乡市传染病医院肝病科，河南　新乡　453000；2.新乡市传染病医院检验科，河南　新乡　453000；3.河南师范大学生命科学学院，河南　新乡　453000）
Author(s):
WEN Zhengyan1; SUN Chuanjun2; YANG Xianguang3
（1.Department of Hepatology,Xinxiang Infectious Disease Hospital,Xinxiang 453000,Henan Province,China；2.Department of Clinical Laboratory,Xinxiang Infectious Disease Hospital,Xinxiang 453000,Henan Province,China；3.School of Life Science,Henan Normal University，Xinxiang 453000,Henan Province,China）
关键词:
乙型肝炎病毒; 肝细胞肝癌; 混合谱系激酶结构域样蛋白; caspase-8; 受体相互作用蛋白激酶3
Keywords:
hepatitis B virus; hepatocellular carcinoma; mixed lineage kinase domain-like protein; caspase-8; receptor interacting protein kinase 3
分类号:
R512.6+2
DOI:
10.7683/xxyxyxb.2023.07.005
文献标志码:
A
摘要:
目的　探讨混合谱系激酶结构域样蛋白（MLKL）、caspase-8及受体相互作用蛋白激酶3（RIPK3）mRNA在不同阶段乙型肝炎病毒（HBV）感染患者中的表达水平及诊断价值。
方法　选择2016年11月至2019年11月新乡市传染病医院收治的175例HBV感染患者为研究对象，根据病情程度将患者分为慢性乙型肝炎（CHB）组（n=67）、肝硬化（LC）组（n=61）和肝细胞肝癌（HCC）组（n=47）；另选择同期于本院体检的80例体检健康者为对照组。采集各组受试者外周静脉血，应用实时荧光定量聚合酶链反应法检测外周血单个核细胞（PBMC）中MLKL、caspase-8及RIPK3 mRNA 表达水平；采用Pearson相关检验分析HBV感染不同阶段患者PBMC中MLKL、caspase-8及RIPK3 mRNA表达水平的相关性，受试者操作特征曲线下面积（AUC）评估MLKL、caspase-8及RIPK3 mRNA表达水平对不同阶段HBV感染患者的鉴别诊断价值。
结果　4组受试者PBMC中MLKL、RIPK3、caspase-8 mRNA表达水平比较差异有统计学意义（F=1 019.364、1 009.381、159.407,P<0.05）。CHB组、LC组、HCC组患者PBMC中MLKL、RIPK3 mRNA表达水平显著高于对照组，caspase-8 mRNA表达水平显著低于对照组（P<0.05）。LC组、HCC组患者PBMC中MLKL、RIPK3 mRNA表达水平显著高于CHB组，caspase-8 mRNA表达水平显著低于CHB组（P<0.05）。HCC组患者PBMC中MLKL、RIPK3 mRNA表达水平显著高于LC组，caspase-8 mRNA表达水平显著低于LC组（P<0.05）。Pearson相关检验结果显示，不同阶段HBV感染组患者PBMC中MLKL mRNA表达与RIPK3 mRNA表达呈正相关（r=0.414、0.432、0.449,P<0.01），MLKL mRNA表达与caspase-8 mRNA表达呈负相关（r=-0.556、-0.378、-0.721,P<0.01），RIPK3 mRNA表达与caspase-8 mRNA表达呈负相关（r=-0.415、-0.400、-0.416,P<0.01）。PBMC中MLKL、caspase-8及RIPK3 mRNA表达水平鉴别CHB和HCC的AUC分别为0.918、0.859和0.912，三者联合鉴别CHB和HCC的AUC为0.945。PBMC中MLKL、caspase-8及RIPK3 mRNA表达水平鉴别LC和HCC的AUC分别为0.768、0.834和0.839，三者联合鉴别LC和HCC的AUC为0.895。
结论　HBV感染不同阶段患者PBMC中MLKL、caspase-8及RIPK3 mRNA 表达水平显著上升，且三者之间存在显著相关性，MLKL、caspase-8及RIPK3 mRNA 表达水平可作为鉴别诊断不同阶段HBV感染患者的生物学标志物。
Abstract:
Objective　To investigate the expression and diagnostic value of mixed lineage kinase domain-like protein(MLKL),caspase-8 and receptor interacting protein kinase 3(RIPK3) mRNA in patients at different stages of hepatitis B virus(HBV) infection.
Methods　A total of 175 HBV infected patients admitted to Xinxiang Infectious Disease Hospital from November 2016 to November 2019 were selected as the study subjects,and they were divided into chronic hepatitis B(CHB) group(n=67),liver cirrhosis(LC) group(n=61) and hepatocellular carcinoma(HCC) group(n=47) according to the disease severity of patients.Another 80 healthy subjects who underwent physical examination in the hospital during the same period were selected as the control group.Peripheral venous blood was collected from all subjects and the expression levels of MLKL,caspase-8 and RIPK3 mRNA in peripheral blood mononuclear cell (PBMC) were detected by quantitative real-time fluorescence polymerase chain reaction.The correlation between the MLKL,caspase-8 and RIPK3 mRNA expression levels in PBMC of patients with HBV infection at different stages was analyzed by Pearson correlation test.The differential diagnostic value of expression levels of MLKL,caspase-8 and RIPK3 mRNA on different stages of HBV infection was evaluated by area under the curve(AUC) in receiver operating characteristic curve.
Results　There was significant difference in the expression levels of MLKL,RIPK3 and caspase-8 mRNA in PBMC of subjects among the four groups(F=1 019.364,1 009.381,159.407;P<0.05).The expression levels of MLKL and RIPK3 mRNA in PBMC of patients in the CHB,LC and HCC groups were significantly higher than those in the control group,while the expression level of caspase-8 mRNA was significantly lower than that in the control group(P<0.05).The expression levels of MLKL and RIPK3 mRNA in PBMC of patients in the LC and HCC groups were significantly higher than those in the CHB group,while the expression level of caspase-8 mRNA was significantly lower than that in the CHB group(P<0.05).The expression levels of MLKL and RIPK3 mRNA in PBMC of patients in the HCC group were significantly higher than those in the LC group,while the expression level of caspase-8 mRNA was significantly lower than that in the LC group(P<0.05).Pearson correlation test results showed that the expression of MLKL mRNA was positively correlated with the expression RIPK3 mRNA in PBMC of patients with different stages of HBV infection(r=0.414,0.432,0.449;P<0.01);the expression of MLKL mRNA was negatively correlated with the expression of caspase-8 mRNA(r=-0.556,-0.378,-0.721;P<0.01);and the expression of RIPK3 mRNA was negatively correlated with the expression of caspase-8 mRNA(r=-0.415,-0.400,-0.416;P<0.01).The AUC of MLKL,caspase-8 and RIPK3 mRNA expression levels in PBMC in identifying of CHB and HCC was 0.918,0.859,0.912,respectively;the AUC of above three indexes in combination in identifying of CHB and HCC was 0.945.The AUC of MLKL,caspase-8 and RIPK3 mRNA expression levels in PBMC in identifying of LC and HCC was 0.768,0.834 and 0.839,respectively;the AUC of above three indexes in combination in identifying of LC and HCC was 0.895.
Conclusion　The expression levels of MLKL,caspase-8 and RIPK3 mRNA in PBMC of patients at different stages of HBV infection are significantly increased;and there is a significant correlation among the three indicators.The expression levels of MLKL,caspase-8 and RIPK3 mRNA can be used as biological markers for differential diagnosis of patients at different stages of HBV infection.

参考文献/References:

［1］　KASAP B,BURUK C K,KAKLIKKAYA N,et al.Comparison of mRNA levels of stimulator of interferon genes(STING) in individuals with natural immunity to hepatitis b virus(HBV),and in those with chronic hepatitis B infection and without HBV［J］.Mikrobiyol Bul,2020,54(1):66-78.
［2］　KIM G W,IMAM H,KHAN M,et al.HBV-induced increased N6 methyladenosine modification of PTEN RNA affects innate immunity and contributes to HCC［J］.Hepatology,2021,73(2):533-547.
［3］　HOAN N X,HUYEN P T M,BINH M T,et al.Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression［J］.Sci Rep,2021,11(1):7772-7781.
［4］　王诗婧,彭军.调节性坏死:认识和防治损伤相关性疾病的新途径［J］.中国药理学通报,2017,33(2):153-157.
WANG S J,PENG J.Regulatory necrosis:a novel way to recognize and prevent injury-relevant diseases［J］.Chin Pharmacol Bull,2017,33(2):153-157.
［5］　中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南（2015年版）［J］.实用肝脏病杂志,2016,19(3):389-400.
CHINESE SOCIETY OF HEPATOLOGY，CHINESE MEDICAL ASSOCIATION,CHINESE SOCIETY OF INFECTIOUS DISEASES，CHINESE MEDICAL ASSOCIATION.The guideline of prevention and treatment for chronic hepatitis B(2015 version)［J］.J Pract Hepatol,2016,19(3):389-400.
［6］　杨鑫,杨道坤.Toll样受体在慢性乙型肝炎患者免疫损伤中的作用研究进展［J］.新乡医学院学报,2022,39(4):392-395.
YANG X,YANG D K.Research progress on the role of Toll like receptor in immunological injury of patients with chronic hepatitis B［J］.J Xinxiang Med Univ,2022,39(4):392-395.
［7］　HAYASHI S,NAGAOKA K,TANAKA Y.Blood-based biomarkers in hepatitis B virus-related hepatocellular carcinoma,including the viral genome and glycosylated proteins［J］.Int J Mol Sci,2021,22(20):11051-11067.
［8］　LIU S,JOSHI K,DENNING M F,et al.RIPK3 signaling and its role in the pathogenesis of cancers［J］.Cell Mol Life Sci,2021,78(23):7199-7217.
［9］　肖真,张银妆,匡圆圆,等.冠状动脉粥样硬化性心脏病患者血浆RIPK1,RIPK3及MLKL水平变化及其临床预测价值［J］.中南大学学报（医学版）,2020,45(9):1096-1103.
XIAO Z,ZHANG Y Z,KUANG Y Y,et al.Changes in plasma levels of RIPK1,RIPK3,and MLKL in patients with coronary atherosclerotic heart disease and its clinical predictive value［J］.J Cent South Univ（Med Sci),2020,45(9):1096-1103.
［10］　YANG D,LIANG Y,ZHAO S,et al.ZBP1 mediates interferon-induced necroptosis［J］.Cell Mol Immunol,2020,17(4):356-368.
［11］　陈少慕,张标,冯军.混合系列蛋白激酶样结构域蛋白在非小细胞肺癌组织的表达及其临床意义［J］.中华实验外科杂志,2018,35(12):2333-2335.
CHEN S M,ZHANG B,FENG J.Decreased mixed lineage kinase domain-like was an unfavourable prognostic factor in non-small-cell lung carcinoma［J］.Chin J Exper Surg,2018,35(12):2333-2335.
［12］　TAN Y,SEMENTINO E,CHEUNG M,et al.Somatic epigenetic silencing of RIPK3 inactivates necroptosis and contributes to chemoresistance in malignant mesothelioma［J］.Clin Cancer Res,2021,27(4):1200-1213.
［13］　CONEV N V,DIMITROVA E G,BOGDANOVA M K,et al.RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer［J］.Clin Invest Med,2019,42(1):E31-E38.
［14］　VERGARA G A,EUGENIO G C,MALHEIROS S M F,et al.RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping［J］.J Neurooncol,2020,147(3):587-594.
［15］　LIN C C,MABE N W,LIN Y T,et al.RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence［J］.Cell Death Differ,2020,27(7):2234-2247.
［16］　FRITSCH M,GNTHER S D,SCHWARZER R,et al.Caspase-8 is the molecular switch for apoptosis,necroptosis and pyroptosis［J］.Nature,2019,575(7784):683-687.
［17］　WANG C,YAO B,XU M,et al.RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC［J］.Tumour Biol,2016,37(11):15305-15313.
［18］　李新帅,华钰赟,陈云,等.受体相互作用蛋白激酶3的病理生理学作用及研究进展［J］.生理科学进展,2021,52(4):297-302.
LI X S,HUA Y Y,CHEN Y,et al.The pathophysiology and perspective of receptor interacting protein kinase 3［J］.Prog Physiol Sci,2021,52(4):297-302.
［19］　AFONSO M B,RODRIGUES P M,MATEUS-PINHEIRO M,et al.RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease［J］.Gut,2021,70(12):2359-2372.
［20］　HAN L Y,YANG J R,ZHAO Z H,et al.RIPK3 mRNA level acts as a diagnostic biomarker in hepatitis B virus-associated hepatocellular carcinoma［J］.Pathol Res Pract,2020,216(10):153147-153152.
（

相似文献/References:

[1]许世琴,张倩,高同举.荧光定量聚合酶链反应检测乙肝病毒DNA的临床意义[J].新乡医学院学报,2001,18(04):292.
[2]焦栓林,许丽芝,申德林,等.拉米夫定治疗慢性乙型肝炎过程中的YMDD变异及其临床意义[J].新乡医学院学报,2002,19(06):465.
[3]焦栓林,许丽芝,申德林,等.拉米夫定治疗慢性乙型肝炎过程中的YMDD变异及其临床意义[J].新乡医学院学报,2002,19(06):465.
[4]许德军,李太平,郎振为.巨细胞病毒在慢性乙型肝炎患者肝组织中的表达[J].新乡医学院学报,2006,23(05):529.
[5]卫萍,成军,楚庸烈,等.应用酵母双杂交技术筛选与前S1蛋白反式激活蛋白3结合的肝细胞蛋白基因 TitleFilter('chTitle');[J].新乡医学院学报,2010,27(04):329.
[6]丁肖华,毛恺,邱耕,等.反向点杂交检测肝癌细胞DNA 甲基化方法的建立[J].新乡医学院学报,2012,29(01):000.
[7]陈占军,丁小华,裴 容,等.综合护理干预对老年乙型肝炎肝硬化合并２型糖尿病患者的影响[J].新乡医学院学报,2014,31(05):405.[doi:10.7683/xxyxyxb.2014.05.026]
[8]叶 明.2种方案阻断乙型肝炎病毒母婴传播效果比较[J].新乡医学院学报,2014,31(11):915.[doi:10.7683/xxyxyxb.2014.11.014]
[9]赵佳,尚文会,田召兵,等.不同商品化试剂盒定量检测肝癌晚期患者乙型肝炎病毒 DNA结果的差异[J].新乡医学院学报,2022,39(12):1155.[doi:10.7683/xxyxyxb.2022.12.010]
　ZHAO Jia,SHANG Wenhui,TIAN Zhaobing,et al.Difference of quantitative detection of hepatitis B virus DNA in patients with advanced liver cancer by different commercial kits[J].Journal of Xinxiang Medical University,2022,39(7):1155.[doi:10.7683/xxyxyxb.2022.12.010]
[10]王天宝,王　扬,罗　磊,等.乙型肝炎病毒与戊型肝炎病毒重叠感染患者T淋巴细胞变化及相关临床危险因素分析[J].新乡医学院学报,2018,35(11):1013.[doi:10.7683/xxyxyxb.2018.11.017]
　WANG Tian-bao,WANG Yang,LUO Lei,et al.Analysis of T lymphocyte changes and related clinical risk factors in patients with hepatitis B virus and hepatitis E virus superinfection[J].Journal of Xinxiang Medical University,2018,35(7):1013.[doi:10.7683/xxyxyxb.2018.11.017]

更新日期/Last Update: 2023-07-05